Sana Biotechnology Inc vs United Airlines Holdings Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while United Airlines Holdings Inc trades at $118.05 (market cap $38.15B). The key difference: United Airlines Holdings Inc is far larger — about 43.7× Sana Biotechnology Inc's market cap, and United Airlines Holdings Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | UAL | |
|---|---|---|
Market Cap | $873.84M | $38.15B |
Sector | Health | Industrials |
52-Week High | $5.92 | $136.11 |
52-Week Low | $2.68 | $84.57 |
Enterprise Value | $848.03M | $55.18B |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →